Urinary 8-isoprostaglandin F2α level in Behçet's disease

Prostaglandins and Other Lipid Mediators

Volumn 78, Issue 1-4, 2005, Pages 96-106

  Özdöl, Nalan Çiçek ^a,b   Ateş, Aşkin ^a,c   Aydintuǧ, Olcay Tiryaki ^a   Melli, Mehmet ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Ankara Numune Research and Education Hospital   (Turkey)

Author keywords

8 Isoprostaglandin F2 ; Beh et's disease; Lipid peroxidation; Reactive oxygen species; Systemic lupus erythematosus

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IN VIVO STUDY; LIPID PEROXIDATION; LITERATURE; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROSTAGLANDINS A;

EID: 27844470579     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2005.04.002     Document Type: Article

References (31)

1. Y. Oshima, T. Shimizu, and R. Yokohari Clinical studies on Behçet's syndrome Ann Rheum Dis 9 1962 701 714
2. H. Behçet Über rezidivierende aphtöse, durc ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien Dermatol Wochenschr 105 1937 1152 1157
3. Y. Niwa, S. Miyake, T. Sakane, M. Shingu, and M. Yokoyama Auto-oxidative damage in Behçet's disease-endothelial cell damage following the elevated oxygen radicals generated stimulated neutrophils Clin Exp Immunol 49 1982 247 255
4. L. Pronai, Y. Ichikawa, H. Nakazawa, and S. Arimori Enhanced superoxide scavenging activity of peripheral blood leucocytes in Behçet's disease-effects of colchicines Clin Exp Rheumatol 9 1991 227 233
5. Tutkak H, Yurtaslani Z, Tokgöz G, Aydintuǧ AO, Düzgün N, Gürler A. Superoxide dismutase activity of plasma, erythrocyte and lymphocytes (T,B) in patients with Behçet's disease. In: Godeau P, Wechsler B, editors. Behçet's disease. Elsevier Science Publishers B.V.
6. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc Natl Acad Sci USA 87 1990 9383 9387
7. J.D. Morrow, J.A. Awad, A. Wu, W.E. Zackert, V.C. Daniel, and L.J. Roberts II Nonenzymatic free radical, catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo J Biol Chem 271 1996 23185 23190
8. K.A. Harrison, and R.C. Murphy Isoleukotrienes are biologically active free radical products of lipid peroxidation J Biol Chem 270 1995 17273 17278
9. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus FEBS Lett 368 1995 225 229
10. 2α and platelet activation in diabetes mellitus. Effects of improved metabolic control and Vitamin E supplementation Circulation 99 1999 224 229
11. 2-isoprostanes in hypercholesterolemia Circulation 98 1998 2822 2828
12. 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans Circulation 96 1997 3314 3320
13. D. Pratico, and N. Delanty Oxidative injury in the central nervous system-focus on Alzheimer's disease Am J Med 109 2000 577 585
14. C.M. Stein, S.B. Tannes, J.A. Award, L.J. Roberts, and J.D. Morrow Evidence of free radical mediated injury (isoprostane overproduction) in scleroderma Arthritis Rheum 39 1996 1146 1150
15. L. Iuliano, D. Pratico, and D. Ferro Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies Blood 90 1997 3931 3935
16. 2α in different rheumatic diseases Ann Rheum Dis 60 2001 627 631
17. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease Lancet 335 1990 1078 1080
18. E. Tan, M.A. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, and N. Rothfield The 1982 revised criteria for the classification of SLE Arthritis Rheum 25 1995 1271 1277
19. P. Pradelles, J. Grassi, and J. Maclouf Enzyme immunoassay of eicosanoids using AchE as label: an alternative to RIA Anal Biochem 57 1985 467 477
20. Y. Ozaki, T. Ohashi, and Y. Niwa Oxygen radicals production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection Inflammation 10 2 1986 119 130
21. B. Oldenburg, H. Van Kats-Renaud, J.C. Koningsberger, C. Van Berge Henegouwen, and B.S. Van Asbeck Chemiluminescence in inflammatory bowel disease: a parameter of inflammatory activity Clin Chim Acta 310 2 2001 151 156
22. F. Tao, B. Gonzalez-Flecha, and L. Kobzik Reactive oxygen species in pulmonary inflammation by ambient particulates Free Radic Biol Med 35 4 2003 327 340
23. 2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes Biochem. Pharmacol. 47 1994 1173 1177
24. W.S. Matthews, R. Mckenna, D.M. Guido, T.W. Petre, R.A. Jolly, and J.D. Morrow A comparison of gas chromatography-mass spectrometry assays for in vivo lipid peroxidation Proceedings of the 41st ASMS Conference on Mass Spectrometry Allied Topics 1993 p. 865A-865B
25. 2-isoprostanes) in human plasma and isolated low density lipoproteins exposed to metal ion-dependent and -independent oxidative stess J Clin Invest 93 1993 998 1004
26. 2-isoprostanes) in smokers N Engl J Med 332 1995 1198 1203
27. M. Reilly, N. Delanty, J.A. Lawson, and G.A. FitzGerald Modulation of oxidant stress in vivo in chronic cigarette smokers Circulation 94 1996 19 25
28. A. Oguogho, G. Lupattelli, B. Palumbo, and H. Sinzinger Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults Vasa 29 2000 103 105
29. 2-isoprostanes in patients with Crohn's disease Am J Gastroenterol 97 2002 99 103
30. 2-isoprostane concentration in probable AD Neurology 52 1999 562 565
31. 2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo FASEB J 12 1998 1777 1783